Baird analyst Tristan Gerra maintains Ambarella (NASDAQ:AMBA) with a Outperform and raises the price target from $90 to $120.
Credit Suisse Maintains Outperform on Merck & Co, Raises Price Target to $126
Credit Suisse analyst Trung Huynh maintains Merck & Co (NYSE:MRK) with a Outperform and raises the price target from $125 to $126.